ad image

Orgenesis

1 / 1
Orgenesis
Investment

Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services

Orgenesis

PR-M11-22-05Nov 07, 2022
Catalent
M&A

Catalent Acquires Orgenesis' Cell Therapy Unit

Catalent

PR-M01-20-NI-046Feb 03, 2020
Secant Group
Collaboration

Secant Group Announces Collaboration between Orgenesis and Atvio Biotech

Secant Group

PR-M08-18-NI-033Aug 09, 2018
1 / 1